Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Turnstone Biologics Corp.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21
   S-1/AS-1/A
Revenues  86.754.8
            Revenue growth  58.4% 
Cost of goods sold  104.968.3
Gross profit  -18.2-13.5
            Gross margin  -21.0%-24.7%
Selling, general and administrative   [+]18.213.5
Other operating expenses  -4.8-60.1
EBITDA   [+]-27.734.4
            EBITDA margin  -32.0%62.8%
Depreciation and amortization  3.91.4
EBIT   [+]-31.633.0
            EBIT margin  -36.5%60.3%
Other income (expense), net  0.90.7
Pre-tax income  -30.733.7
Income taxes  0.10.4
            Tax rate   1.3%
Earnings from continuing ops  0.03.4
Earnings from discontinued ops  0.00.0
Net income  0.03.5
            Net margin  0.0%6.4%
   
Basic EPS   [+]($0.08)$1.60
Diluted EPS   [+]($0.08)$1.28
   
Shares outstanding (basic)   [+]0.02.1
Shares outstanding (diluted)   [+]0.02.7
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy